Development and prospect of clinical research on lung transplantation in post-COVID-19 era
Organ Transplantation
; 12(5):506-511, 2021.
Article
in Chinese
| EMBASE | ID: covidwho-2323425
ABSTRACT
Lung transplantation has been advanced for nearly half a century around the globe, and it has been developed rapidly for over 20 years in China. The field of lung transplantation in China has been gradually integrated into the international community. The outbreak of novel coronavirus pneumonia (COVID-19) in 2020 brought big challenges, as well as diverted the worldwide attention to the development of lung transplantation in China, accelerating international communication and cooperation. With the steadily deepening of clinical and basic research on lung transplantation for severe cases of COVID-19, organ transplant physicians have deepened the understanding and thinking of the maintenance of donors, selection of elderly and pediatric candidates, and perioperative management of recipients, as the future perspective of lung transplantation in China. For interdisciplinary research related to lung transplantation, it is necessary to carry out multi-center clinical trials with qualified study design and constantly promote the theoretic and practical innovation.Copyright © 2021 The authors.
Acute respiratory distress syndrome (ARDS); Ex vivo lung perfusion (EVLP); Extracorporeal membrane oxygenation (ECMO); Lung allocation score (LAS); Lung transplantation; Novel coronavirus pneumonia (COVID-19); Organ allocation; China; clinical research; coronavirus disease 2019; disease severity; graft recipient; human; perioperative care; priority journal; review
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Topics:
Long Covid
Language:
Chinese
Journal:
Organ Transplantation
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS